SCHEMBL21440361

SCHEMBL21440361

O=C(O)CC1CN(CC(=O)OCc2ccccc2)CC1CC(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ CYP2C19 P33261 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ GLA P06280 1/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ CHRM2 P08172 1/20 0.42
▸ CHRM4 P08173 1/20 0.42
▸ CHRM5 P08912 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19966271 0.84 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL23054258 0.82 S1PR5 (0.57) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL21673760 0.82 ALDH1A1 (0.47) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL10859364 0.81 ALDH1A1 (0.61) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL20122597 0.81 ALDH1A1 (0.44) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL19604440 0.81 ALDH1A1 (0.44) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL19604406 0.81 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL19934909 0.81 FUCA1 (0.55) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL24970558 0.81 ALDH1A1 (0.50) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2
SCHEMBL22063763 0.81 ALDH1A1 (0.41) ALDH1A1MAPK1L3MBTL1CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10435389-B2 Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2 Krouzon Pharmaccuticals, Inc. (US) 2019-10-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10435389-B2 Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2 PTPN1, PTPN2, PTPN7 ALDH1A1 3869/4885MAPK1 338/4885L3MBTL1 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback